Kawa Chiu
Chief Technical Officer Abdera Therapeutics
Kawa Chiu is the Chief Technical Officer of Abdera Therapeutics Inc. Kawa joined Abdera in 2022. She brings to Abdera more than 25 years of global manufacturing, supply chain and CMC experience across broad modalities.
Prior to Abdera, Kawa served as the vice president of CMC supply chain at Lyell Immunopharma, a cell therapy company focused on solid tumors. During her tenure, Kawa oversaw CMC programs that enabled three IND approvals, established the company’s autologous patient supply chain, and implemented a progressive cloud based, integrated manufacturing systems. Prior to Lyell, Kawa spent 14 years at Genentech in South San Francisco and at Roche in Basel, Switzerland in roles including head of Oceanside drug substance manufacturing, global head of technical operation strategy, global head of biologics operational excellence and global head of supply planning. Kawa started her career and held a number of manufacturing positions at Merck & Co., Inc.
Kawa holds a B.S. in operations from The Ohio State University, a M.Sc. in Engineering from University of Pennsylvania, an MBA from New York University, and a Master in Public Health from U.C. Berkeley.
Seminars
- Exploring how leveraging radiopharmacies for therapeutic preparation can extend regional coverage, reduce time-to-treatment for short-lived isotopes, and ease pressure on centralized manufacturing
- Understanding regulatory and operational restrictions in compounding manufacturing and radiopharmacy roles
- Discussing strategic partnerships with national pharmacy networks to improve batch consistency, point-of-care readiness, and public/physician trust in decentralized delivery
